Yixintang Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Yixintang Pharmaceutical Group has a total shareholder equity of CN¥8.1B and total debt of CN¥1.5B, which brings its debt-to-equity ratio to 18.7%. Its total assets and total liabilities are CN¥17.5B and CN¥9.4B respectively. Yixintang Pharmaceutical Group's EBIT is CN¥848.0M making its interest coverage ratio 17. It has cash and short-term investments of CN¥3.9B.
Key information
18.7%
Debt to equity ratio
CN¥1.52b
Debt
| Interest coverage ratio | 17x |
| Cash | CN¥3.91b |
| Equity | CN¥8.13b |
| Total liabilities | CN¥9.41b |
| Total assets | CN¥17.54b |
Recent financial health updates
Recent updates
These 4 Measures Indicate That Yixintang Pharmaceutical Group (SZSE:002727) Is Using Debt Reasonably Well
Jul 15
Some Investors May Be Worried About Yixintang Pharmaceutical Group's (SZSE:002727) Returns On Capital
Jun 29Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Intrinsic Value Is Potentially 26% Below Its Share Price
Jun 13Market Cool On Yixintang Pharmaceutical Group Co., Ltd.'s (SZSE:002727) Earnings Pushing Shares 27% Lower
Jun 13Yixintang Pharmaceutical Group (SZSE:002727) Is Due To Pay A Dividend Of CN¥0.40
May 27Yixintang Pharmaceutical Group's (SZSE:002727) Conservative Accounting Might Explain Soft Earnings
May 03Investors Holding Back On Yixintang Pharmaceutical Group Co., Ltd. (SZSE:002727)
Apr 15Return Trends At Yixintang Pharmaceutical Group (SZSE:002727) Aren't Appealing
Mar 06Financial Position Analysis
Short Term Liabilities: 002727's short term assets (CN¥10.5B) exceed its short term liabilities (CN¥7.8B).
Long Term Liabilities: 002727's short term assets (CN¥10.5B) exceed its long term liabilities (CN¥1.6B).
Debt to Equity History and Analysis
Debt Level: 002727 has more cash than its total debt.
Reducing Debt: 002727's debt to equity ratio has increased from 9.8% to 18.7% over the past 5 years.
Debt Coverage: 002727's debt is well covered by operating cash flow (149.5%).
Interest Coverage: 002727's interest payments on its debt are well covered by EBIT (17x coverage).